European Drug Delivery Technologies Market Worth $59.1 Billion by 2017

Pune, Maharashtra, September 4, 2015 (Newswire.com) - Browse 141 market data tables and 20 figures spread through 300 pages and in-depth TOC on “European Drug Delivery Technologies Market”.

http://www.marketsandmarkets.com/Market-Reports/european-drug-delivery-technologies-market-1194.html

Early buyers will receive 10% customization on this report.

This report studies the Europe and drug delivery market, with forecast to 2017.

The European drug delivery market was worth $39.9 billion in the year 2012. This market is expected to grow at a healthy rate over the next five-year period owing to the rising incidences of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing demand for self-administration and home healthcare devices, patent expiries of certain blockbuster drugs and growing focus on pediatric and geriatric patients.

Ask For The PDF Brochure Of This Report:

http://www.marketsandmarkets.com/pdfdownload.asp?id=1194

The European drug delivery market is categorized into nine segments as Oral, Pulmonary, Transdermal, Injectable, Ocular, Nasal, Topical, Implantable and Transmucosal.

Strategic collaborations in the industry, home care drug delivery devices and expanding applications of drug delivery into niche therapeutic areas present tremendous opportunities for the growth of this market. With the increasing geriatric population of Europe, the demand for home care drug delivery devices is also increasing.

Germany is the largest market for drug delivery, followed by France and the U.K. These three countries have a well-established pharmaceutical industry, which has stimulated the growth of the drug delivery market in these regions. The Russian and RoE markets are expected to witness double digit growth over the next five years, owing to the growing investments in the pharmaceutical industry and the development of healthcare infrastructure.

Get The Sample Copy Of This Report:

http://www.marketsandmarkets.com/requestsample.asp?id=1194

Key players in the European drug delivery technologies market are Becton, Dickinson & Company (U.S.), Novartis (Switzerland), AstraZeneca (U.K.), SkyePharma PLC (U.K.), Johnson & Johnson (U.S), Ypsomed Holding AG (Switzerland), GlaxoSmithKline (U.K.), 3M Company (U.S.), and Alkermes (Ireland). Some of the emerging companies in this field include Drug Delivery International (U.K.), Foamix (Israel), QLT (Canada), and Bend Research (U.S.).

About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.
Email: [email protected]